Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
Clin Exp Hypertens
    December 2026
  1. JIN Y, Song T, Jiang T, Wei Y, et al
    FUNDC2 contributes to hypertensive vascular remodeling by regulating mitochondrial dynamics and ferroptosis in perivascular adipose tissue.
    Clin Exp Hypertens. 2026;48:2610587.
    >> Share

  2. ZHAO M, Liu Q, Shi NJ, Li Y, et al
    Gut microbiota and hypertension: role of exercise training.
    Clin Exp Hypertens. 2026;48:2608905.
    >> Share

  3. JIANJUN Y
    Bilateral hypertensive retinopathy (grade 4): Case report and review of the literature on intravitreal injection anti-VEGF therapy.
    Clin Exp Hypertens. 2026;48:2604831.
    >> Share

  4. ZHOU Z, Fang Q, Li X, Li C, et al
    Arachidonic acid intake promotes hypertension and target-organ fibrosis through CYP4A-mediated 20-HETE overproduction: Integrated evidence from human and animal studies.
    Clin Exp Hypertens. 2026;48:2611130.
    >> Share

  5. WANG MJ, Chen CP, Chiu NF, Sun FJ, et al
    Longitudinal trajectory of circulating microRNA-210-3p and its association with low-dose aspirin use in gestational hypertension and preeclampsia: a pilot study.
    Clin Exp Hypertens. 2026;48:2616534.
    >> Share

  6. ZEHIR R, Dogan C, Avci A, Alici G, et al
    Assessment of the safety and effectiveness of catheter-based renal denervation with the symplicity spyral system in patients with resistant hypertension: A single-center experience.
    Clin Exp Hypertens. 2026;48:2617997.
    >> Share

  7. ESKI S, Taskan H, Allahverdiyev S, Yasar S, et al
    Association of carotid body size with left atrial strain and peripheral hemodynamics in patients with hypertension: An exploratory study.
    Clin Exp Hypertens. 2026;48:2621676.
    >> Share

  8. FAN L, Zhou Z, Zhao S, Zhong Z, et al
    Relationship between kidney length and renal risk in malignant hypertension patients with renal thrombotic microangiopathy.
    Clin Exp Hypertens. 2026;48:2617514.
    >> Share

  9. FARAHMAND M, Nazarpour S, Malmir H, Hosseinpour-Niazi S, et al
    Presenting non-insulin-based indices of insulin resistance relevant to pre-hypertension: A systematic review and meta-analysis.
    Clin Exp Hypertens. 2026;48:2625124.
    >> Share

  10. YALCIN MU, Gurses KM, Tuncez A, Tezcan H, et al
    Association of blood pressure dipping status with Naples Prognostic Score and arterial stiffness in newly diagnosed hypertensive patients.
    Clin Exp Hypertens. 2026;48:2627333.
    >> Share

  11. LI H, Li M, Qiu C, Yang Y, et al
    Bulk and single-cell transcriptomics for identification of potential diagnostic biomarkers associated with pulmonary arterial hypertension and integrated stress response and experimental validation.
    Clin Exp Hypertens. 2026;48:2629926.
    >> Share

  12. WU X, Miao J, Peng Z, An X, et al
    Effects of time-restricted eating on blood pressure in children: A cluster randomized controlled trial.
    Clin Exp Hypertens. 2026;48:2635384.
    >> Share

  13. LI G, Zhang JJ, Mou X, Zhuo X, et al
    Mechanisms linking hypertension to cardiovascular and cerebrovascular diseases and their clinical implications: A comprehensive review.
    Clin Exp Hypertens. 2026;48:2631606.
    >> Share

  14. KUCUKSEVGILI B, Dogru MT, Kandemir H, Alp C, et al
    Serum endothelin-1 and endothelin-2 levels in healthy controls and circadian hypertension phenotypes: A comparison of dipper and non-dipper patients.
    Clin Exp Hypertens. 2026;48:2637683.
    >> Share

  15. FAN L, Ding L, Nie J, Wang J, et al
    Hypertensive disorders of pregnancy: A comprehensive review of pathophysiology, diagnosis, treatment, and long-term cardiovascular implications.
    Clin Exp Hypertens. 2026;48:2641542.
    >> Share

  16. THOMAS SM, Anilkumar AS, Veerabathiran R
    Genetic determinants of hypertension: A meta-analysis of AGTR1 and CYP11B2 gene polymorphisms.
    Clin Exp Hypertens. 2026;48:2643329.
    >> Share

  17. KANDEMIR H, Alp C
    Comparative analysis of inflammatory and metabolic indices (HALP score, NLR, LMR, and TyG index) in healthy individuals, dipper, and non-dipper hypertensive phenotypes.
    Clin Exp Hypertens. 2026;48:2657358.
    >> Share

  18. ZHENG Z, Yu Z
    From clinic to home monitoring: Diagnostic strategies and evidence landscape of white-coat uncontrolled hypertension.
    Clin Exp Hypertens. 2026;48:2663394.
    >> Share

  19. ZHOU B, Jiang Y, Hu D, He L, et al
    Synergistic impact of nondipper heart rate and blood pressure on left ventricular hypertrophy in essential hypertension.
    Clin Exp Hypertens. 2026;48:2652134.
    >> Share

    December 2025
  20. SU Y, Zhang M, Xu P, Wen P, et al
    Genetic causal assessment between major depression and hypertension: A two-sample bidirectional Mendelian randomization study.
    Clin Exp Hypertens. 2025;47:2553507.
    >> Share

  21. SUN Z, Dai G, Quan N
    Hypertension accelerates aging: Evidence from NHANES database and Mendelian randomization analyses.
    Clin Exp Hypertens. 2025;47:2559743.
    >> Share

  22. JIANG G, Li X, Fang Z, Shi G, et al
    miPEP31 inhibits the vascular smooth muscle cell proliferation via cooperation with transcription factor Trps1.
    Clin Exp Hypertens. 2025;47:2561235.
    >> Share

  23. ZHOU J, Su Y, He L, Ding N, et al
    Association of different diet quality scores with cardiovascular disease mortality risk in hypertension treatment group.
    Clin Exp Hypertens. 2025;47:2563779.
    >> Share

  24. CHEN L, Wang X, Luo L, Li Y, et al
    The effect of comprehensive intervention on children with anxiety/depression and increased blood pressure.
    Clin Exp Hypertens. 2025;47:2560635.
    >> Share

  25. TIAN X, Zou Y, Zhou Y, Zhang Y, et al
    Investigating non-invasive hemodynamic indicators in hypertension patients with coronary atherosclerotic heart disease.
    Clin Exp Hypertens. 2025;47:2564296.
    >> Share

  26. SONG H, Li J, Lan L, Meng H, et al
    The causal relationship between aspartate aminotransferase and hypertension: A bidirectional Mendelian randomization study.
    Clin Exp Hypertens. 2025;47:2564298.
    >> Share

  27. WU J, Zhu X, Wu Q, Xiao F, et al
    Interdisciplinary collaborative care model combined with family empowerment in patients with comorbid hypertension and diabetes: A study on blood pressure/glucose control and psychosocial adaptation based on the COM-B model.
    Clin Exp Hypertens. 2025;47:2570212.
    >> Share

  28. GU D, Chen M, Yang Y, Lu C, et al
    Targeting the PHD2/HIF-1alpha/HO-1 pathway: A key role of trimetazidine in hypertensive nephropathy.
    Clin Exp Hypertens. 2025;47:2563033.
    >> Share

  29. GUO F, Qin L, Chen B, Xu H, et al
    Predictive model combining blood pressure, glycemic and renal markers for diabetic nephropathy in elderly hypertensive patients with type 2 diabetes.
    Clin Exp Hypertens. 2025;47:2564299.
    >> Share

  30. YE B, Su D, Huang Y, Liu D, et al
    Interaction of circPcmtd1 with HSP90AB1 mediates phosphorylation of AKT to regulate pulmonary arterial hypertension induced by high pulmonary blood flow in rat.
    Clin Exp Hypertens. 2025;47:2583193.
    >> Share

  31. ZHANG S, Tang M, Wu Q, Tan H, et al
    Transcatheter hybrid closure of a large muscular ventricular septal defect with severe pulmonary hypertension using a duct occluder.
    Clin Exp Hypertens. 2025;47:2586068.
    >> Share

  32. XU C, Li Z, Zeng Y, Luo H, et al
    Gastrin signaling in cardiovascular pathophysiology: From molecular crosstalk to clinical implications.
    Clin Exp Hypertens. 2025;47:2584566.
    >> Share

  33. ZHENG Q, Zhao Z, Wang L, Yu C, et al
    Identification of endoplasmic reticulum stress-associated signatures of human pulmonary arterial hypertension: A bioinformatic analysis.
    Clin Exp Hypertens. 2025;47:2584570.
    >> Share

  34. LUO R, Huang Y, Leng Y, Liao W, et al
    Blood pressure variability: From predictive marker to intervention target-breaking the vicious cycle of hypertensive target organ damage.
    Clin Exp Hypertens. 2025;47:2601054.
    >> Share

  35. ZHENG J, Lu C
    Metabolic dysfunction-associated fatty liver disease and risk of hypertension in young adults: A cross-sectional study mediated by inflammatory markers.
    Clin Exp Hypertens. 2025;47:2597852.
    >> Share

  36. WEI X, Li L, Zhao G, Luan Y, et al
    Hypertension and Alzheimer's disease: Pathological interplay, comorbidity risks, and new strategies for synergistic management.
    Clin Exp Hypertens. 2025;47:2595154.
    >> Share

  37. TANAKA M, Akiyama Y, Mori K, Hosaka I, et al
    Machine learning-based analyses of contributing factors for the development of hypertension: a comparative study.
    Clin Exp Hypertens. 2025;47:2449613.
    >> Share

  38. ZHANG K, Deng X, Li Z, Yi C, et al
    Effect of oral potassium supplementation on urinary potassium excretion and its diagnostic value for primary aldosteronism.
    Clin Exp Hypertens. 2025;47:2457768.
    >> Share

  39. YANG H, Xing H, Zou X, Jin M, et al
    Efficacy and safety of intensive blood pressure control in patients over 60 years: A systematic review and meta-analysis.
    Clin Exp Hypertens. 2025;47:2465399.
    >> Share

  40. HAN JH, Sharapatov Y, Do MT, Kim SY, et al
    Safety and efficacy of extravascular renal denervation using HyperQure renal denervation system in short-term swine model of hypertension.
    Clin Exp Hypertens. 2025;47:2474520.
    >> Share

  41. ZHANG J, Zhang W, Yang Z, Fan B, et al
    Cinnamaldehyde alleviates pulmonary hypertension by affecting vascular remodeling through the TLR4/NF-kB/HIF-1a pathway.
    Clin Exp Hypertens. 2025;47:2486829.
    >> Share

  42. HUANG Y, Li Z, Zhu J, Xiao L, et al
    Construction of a risk prediction model for adverse pregnancy outcomes in primipara with gestational diabetes mellitus combined with pregnancy-induced hypertension syndrome.
    Clin Exp Hypertens. 2025;47:2492621.
    >> Share

  43. WU D, Xiong J, Huang Y, Yuan Y, et al
    Establishment of a lupus-prone mouse model of pulmonary arterial hypertension with intermittent hypoxia: functional, biochemical and histological verifications.
    Clin Exp Hypertens. 2025;47:2500383.
    >> Share

  44. XU J, Zhao J, Gu J, Wang W, et al
    Serum uric acid levels as a causal factor in hypertension: Insights from Mendelian randomization analysis.
    Clin Exp Hypertens. 2025;47:2496514.
    >> Share

  45. LIU X, Tan X, Su Y, Zou L, et al
    Anthocyanin attenuates pulmonary arterial hypertension and associated heart failure via improving mitochondrial function through Nrf2-dependent mechanism.
    Clin Exp Hypertens. 2025;47:2503805.
    >> Share

  46. GUO S, Su Y, Li Y, Li C, et al
    The causal relationship between circulating metabolites and gestational hypertension, pre-eclampsia, eclampsia: A bidirectional two-sample Mendelian randomization study.
    Clin Exp Hypertens. 2025;47:2508787.
    >> Share

  47. YESILDAG M, Duksal F
    Comorbidities and anthropometric parameters in obstructive sleep apnea syndrome: a phenotype-based study.
    Clin Exp Hypertens. 2025;47:2512136.
    >> Share

  48. XU Y, Deng C, Liang X
    Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension.
    Clin Exp Hypertens. 2025;47:2512130.
    >> Share

  49. HUANG X, Hu W, Chen L, Ma L, et al
    Mechanistic study of the association between microRNA-126 and hypertension in obstructive sleep apnea-hypopnea syndrome.
    Clin Exp Hypertens. 2025;47:2511056.
    >> Share

  50. BIRD GS, Lin YP, Tucker CJ, Mueller G, et al
    L-type calcium channel blockers at therapeutic concentrations are not linked to CRAC channels and heart failure.
    Clin Exp Hypertens. 2025;47:2515924.
    >> Share

  51. CHEN X, Sun L, Xuan K, Zong A, et al
    The role of immune mechanisms in hypertension and advances in immunomodulatory research.
    Clin Exp Hypertens. 2025;47:2535328.
    >> Share

    December 2024
  52. LAN C, Fang G, Qiu C, Li X, et al
    Inhibition of DYRK1A attenuates vascular remodeling in pulmonary arterial hypertension via suppressing STAT3/Pim-1/NFAT pathway.
    Clin Exp Hypertens. 2024;46:2297642.
    >> Share

  53. SUN Y, Shang Q
    Research hotspots and trends regarding microRNAs in hypertension: a bibliometric analysis.
    Clin Exp Hypertens. 2024;46:2304017.
    >> Share

  54. HE C, Li R, Yang J, Shen H, et al
    Optimizing the aldosterone-to-renin ratio cut-off for screening primary aldosteronism based on cardiovascular risk: a collaborative study.
    Clin Exp Hypertens. 2024;46:2301571.
    >> Share

  55. YUAN Y, Shi J, Sun W, Kong X, et al
    The positive association between the atherogenic index of plasma and the risk of new-onset hypertension: a nationwide cohort study in China.
    Clin Exp Hypertens. 2024;46:2303999.
    >> Share

  56. LIU Y, Lv Z, Zhou S, Fu Z, et al
    A smartwatch sphygmomanometer-based model for predicting short-term new-onset hypertension in individuals with high-normal blood pressure: a cohort study.
    Clin Exp Hypertens. 2024;46:2304023.
    >> Share

  57. LU J, Li Z, Yang Y, Wei F, et al
    Chronic exercise improves renal AT(1) and ETB receptor functions via modulating GRK4 expression in obese Zucker rats.
    Clin Exp Hypertens. 2024;46:2323532.
    >> Share

  58. DENG X, Luo H, He J, Deng W, et al
    Omentin-1 ameliorates pulmonary arterial hypertension by inhibiting endoplasmic reticulum stress through AMPKalpha signaling.
    Clin Exp Hypertens. 2024;46:2332695.
    >> Share

  59. YANG C, Song Y, Wang P
    Relationship between triglyceride-glucose index and new-onset hypertension in general population-a systemic review and meta-analysis of cohort studies.
    Clin Exp Hypertens. 2024;46:2341631.
    >> Share

  60. REN F, Yang M, Liu G, Qi Y, et al
    SIRT5-mediated PRKAA2 succinylation ameliorates apoptosis of human placental trophoblasts in hypertensive disorder complicating pregnancy.
    Clin Exp Hypertens. 2024;46:2358030.
    >> Share

  61. XU W, Gao X, Luo H, Chen Y, et al
    FGF21 attenuates salt-sensitive hypertension via regulating HNF4alpha/ACE2 axis in the hypothalamic paraventricular nucleus of mice.
    Clin Exp Hypertens. 2024;46:2361671.
    >> Share

  62. LIU S, Zhang H, Wu M, Zhou Z, et al
    Association between the triglyceride-glucose index and carotid artery plaque burden in patients with primary hypertension: A cross-sectional study.
    Clin Exp Hypertens. 2024;46:2383232.
    >> Share

  63. YIN L, Zhang X, Zhang H, Li R, et al
    Analysis of the current status and associated risk factors of cognitive function in Tibetan hypertensive patients at various altitudes.
    Clin Exp Hypertens. 2024;46:2393331.
    >> Share

  64. YANG L, Zhu X, Zhu J, Hu Z, et al
    Gestational diabetes causes hyperactivity of the sympathetic nervous system and hypertension in adult mice offspring.
    Clin Exp Hypertens. 2024;46:2402260.
    >> Share

  65. MAO J, Zhang X, Wang C, Peng S, et al
    Irisin mitigates salt-sensitive hypertension via regulating renal AMPK-Rac1 pathway.
    Clin Exp Hypertens. 2024;46:2402258.
    >> Share

    December 2023
  66. WANG Y, Xia M, Lu J, Wang T, et al
    TIP60 mediates stress-induced hypertension via promoting glutamate(dmPFC-)(to-)(vCA1) release.
    Clin Exp Hypertens. 2023;45:2259130.
    >> Share

  67. CAI X, Song S, Hu J, Zhu Q, et al
    Body roundness index improves the predictive value of cardiovascular disease risk in hypertensive patients with obstructive sleep apnea: a cohort study.
    Clin Exp Hypertens. 2023;45:2259132.
    >> Share

  68. WU W, Chen Y, Wu K, Zheng H, et al
    Accumulated exposure to high non-high-density lipoprotein cholesterol increases the risk of cardiovascular diseases in hypertensive individuals: An 11-year prospective cohort study.
    Clin Exp Hypertens. 2023;45:2264540.
    >> Share

  69. HU S, Zhang Y, Qiu C, Li Y, et al
    RGS10 inhibits proliferation and migration of pulmonary arterial smooth muscle cell in pulmonary hypertension via AKT/mTORC1 signaling.
    Clin Exp Hypertens. 2023;45:2271186.
    >> Share

  70. PANG J, Qian L, Che X, Lv P, et al
    TyG index is a predictor of all-cause mortality during the long-term follow-up in middle-aged and elderly with hypertension.
    Clin Exp Hypertens. 2023;45:2272581.
    >> Share

  71. YU W, Zhang Q, Qiu Y, Chen H, et al
    CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells.
    Clin Exp Hypertens. 2023;45:2272062.
    >> Share

  72. ZHOU X, Zhang L, Lin X, Chen X, et al
    Thrombospondin 2 is a novel biomarker of essential hypertension and associated with nocturnal Na(+) excretion and insulin resistance.
    Clin Exp Hypertens. 2023;45:2276029.
    >> Share

  73. HUA R, Liu B, He W, Zhang H, et al
    Calcitriol reverses age-related hypertension via downregulating renal AP1/AT(1)R pathway through regulating mitochondrial function.
    Clin Exp Hypertens. 2023;45:2277653.
    >> Share

  74. TANG L, Cai Q, Wang X, Li X, et al
    Canagliflozin ameliorates hypobaric hypoxia-induced pulmonary arterial hypertension by inhibiting pulmonary arterial smooth muscle cell proliferation.
    Clin Exp Hypertens. 2023;45:2278205.
    >> Share

  75. LIU H, Li Y, Li M, Xie L, et al
    Follistatin-like 1 protects endothelial function in the spontaneously hypertensive rat by inhibition of endoplasmic reticulum stress through AMPK-dependent mechanism.
    Clin Exp Hypertens. 2023;45:2277654.
    >> Share

  76. TIAN X, Feng J, Chen S, Zhang Y, et al
    Baseline and longitudinal cardiovascular health using Life's Essential 8 metrics with the risk of incident hypertension.
    Clin Exp Hypertens. 2023;45:2271190.
    >> Share

  77. YANG J, Jiang G, Huang L, Liu Z, et al
    The Long non-coding RNA MALAT1 functions as a competing endogenous RNA to regulate vascular remodeling by sponging miR-145-5p/HK2 in hypertension.
    Clin Exp Hypertens. 2023;45:2284658.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016